Galenica Sante AG (GALE) - Net Assets
Based on the latest financial reports, Galenica Sante AG (GALE) has net assets worth CHF1.49 Billion CHF (≈ $1.88 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF3.34 Billion ≈ $4.23 Billion USD) and total liabilities (CHF1.86 Billion ≈ $2.35 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Galenica Sante AG (GALE) total assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CHF1.49 Billion |
| % of Total Assets | 44.4% |
| Annual Growth Rate | 17.26% |
| 5-Year Change | 20.37% |
| 10-Year Change | 344.34% |
| Growth Volatility | 41.8 |
Galenica Sante AG - Net Assets Trend (2013–2025)
This chart illustrates how Galenica Sante AG's net assets have evolved over time, based on quarterly financial data. Check how tangible is Galenica Sante AG's equity to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Galenica Sante AG (2013–2025)
The table below shows the annual net assets of Galenica Sante AG from 2013 to 2025. For live valuation and market cap data, see Galenica Sante AG market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CHF1.49 Billion ≈ $1.88 Billion |
-4.31% |
| 2024-12-31 | CHF1.55 Billion ≈ $1.96 Billion |
+5.20% |
| 2023-12-31 | CHF1.48 Billion ≈ $1.87 Billion |
+18.07% |
| 2022-12-31 | CHF1.25 Billion ≈ $1.58 Billion |
+1.28% |
| 2021-12-31 | CHF1.23 Billion ≈ $1.56 Billion |
+17.12% |
| 2020-12-31 | CHF1.05 Billion ≈ $1.33 Billion |
+5.38% |
| 2019-12-31 | CHF999.54 Million ≈ $1.26 Billion |
+7.06% |
| 2018-12-31 | CHF933.60 Million ≈ $1.18 Billion |
+8.37% |
| 2017-12-31 | CHF861.51 Million ≈ $1.09 Billion |
+157.78% |
| 2016-12-31 | CHF334.20 Million ≈ $422.53 Million |
+28.94% |
| 2015-12-31 | CHF259.19 Million ≈ $327.69 Million |
+7.88% |
| 2014-12-31 | CHF240.26 Million ≈ $303.76 Million |
+9.36% |
| 2013-12-31 | CHF219.71 Million ≈ $277.77 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Galenica Sante AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 611.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CHF1.49 Billion | 100.68% |
| Common Stock | CHF5.00 Million | 0.34% |
| Total Equity | CHF1.48 Billion | 100.00% |
Galenica Sante AG Competitors by Market Cap
The table below lists competitors of Galenica Sante AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Persimmon Plc
F:OHP
|
$4.09 Billion |
|
Caihong Display Devices Co Ltd
SHG:600707
|
$4.10 Billion |
|
Jiangsu Guoxin Corp Ltd
SHE:002608
|
$4.10 Billion |
|
Monday.Com Ltd
NASDAQ:MNDY
|
$4.10 Billion |
|
Shanghai Junshi Biosciences Co Ltd
SHG:688180
|
$4.09 Billion |
|
Guizhou Space Appliance Co Ltd
SHE:002025
|
$4.09 Billion |
|
PBF Energy Inc
NYSE:PBF
|
$4.08 Billion |
|
Global Health Limited
NSE:MEDANTA
|
$4.08 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Galenica Sante AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,548,694,000 to 1,481,901,000, a change of -66,793,000 (-4.3%).
- Net income of 181,099,000 contributed positively to equity growth.
- Dividend payments of 115,113,000 reduced retained earnings.
- Share repurchases of 14,008,000 reduced equity.
- New share issuances of 6,043,000 increased equity.
- Other factors decreased equity by 124,814,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CHF181.10 Million | +12.22% |
| Dividends Paid | CHF115.11 Million | -7.77% |
| Share Repurchases | CHF14.01 Million | -0.95% |
| Share Issuances | CHF6.04 Million | +0.41% |
| Other Changes | CHF-124.81 Million | -8.42% |
| Total Change | CHF- | -4.31% |
Book Value vs Market Value Analysis
This analysis compares Galenica Sante AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.89x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 18.66x to 2.89x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | CHF4.61 | CHF85.95 | x |
| 2015-12-31 | CHF5.08 | CHF85.95 | x |
| 2016-12-31 | CHF6.59 | CHF85.95 | x |
| 2017-12-31 | CHF17.47 | CHF85.95 | x |
| 2018-12-31 | CHF18.90 | CHF85.95 | x |
| 2019-12-31 | CHF20.13 | CHF85.95 | x |
| 2020-12-31 | CHF21.16 | CHF85.95 | x |
| 2021-12-31 | CHF24.73 | CHF85.95 | x |
| 2022-12-31 | CHF25.01 | CHF85.95 | x |
| 2023-12-31 | CHF29.49 | CHF85.95 | x |
| 2024-12-31 | CHF31.04 | CHF85.95 | x |
| 2025-12-31 | CHF29.71 | CHF85.95 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Galenica Sante AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.22%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.38%
- • Asset Turnover: 1.24x
- • Equity Multiplier: 2.26x
- Recent ROE (12.22%) is below the historical average (17.86%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 35.53% | 2.90% | 1.65x | 7.42x | CHF58.79 Million |
| 2015 | 31.93% | 2.78% | 1.68x | 6.82x | CHF55.72 Million |
| 2016 | 25.30% | 2.77% | 1.52x | 6.02x | CHF50.43 Million |
| 2017 | 13.86% | 3.78% | 1.75x | 2.10x | CHF33.08 Million |
| 2018 | 15.87% | 4.65% | 1.70x | 2.00x | CHF54.60 Million |
| 2019 | 12.58% | 3.78% | 1.50x | 2.22x | CHF25.64 Million |
| 2020 | 16.45% | 4.95% | 1.54x | 2.16x | CHF67.52 Million |
| 2021 | 13.66% | 4.37% | 1.47x | 2.13x | CHF44.93 Million |
| 2022 | 13.26% | 4.11% | 1.51x | 2.14x | CHF40.57 Million |
| 2023 | 11.80% | 4.63% | 1.25x | 2.03x | CHF26.46 Million |
| 2024 | 11.81% | 4.67% | 1.28x | 1.98x | CHF28.08 Million |
| 2025 | 12.22% | 4.38% | 1.24x | 2.26x | CHF32.91 Million |
Industry Comparison
This section compares Galenica Sante AG's net assets metrics with peer companies in the Medical Distribution industry.
No peer company data available for comparison.
About Galenica Sante AG
Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients … Read more